Measures soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) and calculates their ratio.
Used during the second and third trimesters to support assessment of suspected preeclampsia and short-term risk, alongside blood pressure, urine protein and other clinical findings.